Ecopetrol SA(EC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

EC Ecopetrol SA

Closed 03-04 16:00:00 EST

11.59

-0.10

-0.86%

盘后11.57

-0.02-0.17%

19:58 EST

High11.84	Low11.56	Vol2.16M
Open11.59	D1 Closing11.69	Amplitude2.40%
Mkt Cap23.83B	Tradable Cap2.71B	Total Shares2.06B
T/O25.20M	T/O Rate0.93%	Tradable Shares233.42M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"EC","market":"US","secType":"STK","nameCN":"Ecopetrol SA","latestPrice":11.59,"timestamp":1772658000000,"preClose":11.69,"halted":0,"volume":2159494,"hourTrading":{"tag":"盘后","latestPrice":11.57,"preClose":11.59,"latestTime":"19:58 EST","volume":25411,"amount":295216.9059,"timestamp":1772672285041,"change":-0.02,"changeRate":-0.001726,"amplitude":0.014668},"delay":0,"changeRate":-0.008554319931565411,"floatShares":233420503,"shares":2055834734,"eps":1.411241,"marketStatus":"Closed","change":-0.1,"latestTime":"03-04 16:00:00 EST","open":11.59,"high":11.8414,"low":11.5604,"amount":25198308.399798,"amplitude":0.024038,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.411241,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1772701200000},"marketStatusCode":5,"adr":1,"adrRate":20,"listingDate":1221710400000,"exchange":"NYSE","adjPreClose":11.69,"dividendRate":0.085505,"preHourTrading":{"tag":"盘前","latestPrice":11.62,"preClose":11.69,"latestTime":"09:28 EST","volume":12532,"amount":146208.375196,"timestamp":1772634480235,"change":-0.07,"changeRate":-0.005988,"amplitude":0.021386},"postHourTrading":{"tag":"盘后","latestPrice":11.57,"preClose":11.59,"latestTime":"19:58 EST","volume":25411,"amount":295216.9059,"timestamp":1772672285041,"change":-0.02,"changeRate":-0.001726,"amplitude":0.014668},"volumeRatio":0.597349,"impliedVol":0.4122,"impliedVolPercentile":0.251},"requestUrl":"/m/hq/s/EC","defaultTab":"news","newsList":[{"id":"2617562554","title":"Press Release: Ecopetrol's 2025 Earnings Distribution Proposal","url":"https://stock-news.laohu8.com/highlight/detail?id=2617562554","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617562554?lang=en_us&edition=fundamental","pubTime":"2026-03-05 06:22","pubTimestamp":1772662920,"startTime":"0","endTime":"0","summary":"BOGOTA, Colombia, March 4, 2026 /PRNewswire/ -- Ecopetrol S.A.   announces that, the Company's proposal for the distribution of 2025 earnings, which has been approved by its board of directors, and is intended to be submitted for the consideration of the General Shareholders' Meeting expected to be held on March 26, 2026.Net income after provision for income tax                    9,028,764,859,338. + Release of reserves from previous years                  17,144,573,697,440. - Legal reserves of the current year                          509,081,603,363. Moreover, the board of directors proposes the allocation of COP 21,141,420,537,494 to an occasional reserve to support the Company's financial sustainability and flexibility in the execution of its strategy.Ecopetrol is the largest company in Colombia and one of the main integrated energy companies in the American continent, with more than 19,000 employees. In Colombia, it is responsible for more than 60% of the hydrocarbon production ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EC","BK4201"],"gpt_icon":0},{"id":"2617654025","title":"Ecopetrol options imply 2.6% move in share price post-earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2617654025","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617654025?lang=en_us&edition=fundamental","pubTime":"2026-03-05 04:05","pubTimestamp":1772654717,"startTime":"0","endTime":"0","summary":"Pre-earnings options volume in Ecopetrol (EC) is normal with calls leading puts 9:4. Implied volatility suggests the market is anticipating a move ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ecopetrol-options-imply-2-6-move-in-share-price-post-earnings-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ecopetrol-options-imply-2-6-move-in-share-price-post-earnings-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4201","EC"],"gpt_icon":0},{"id":"2616996369","title":"Ecopetrol SA  expected to post earnings of 34 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2616996369","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616996369?lang=en_us&edition=fundamental","pubTime":"2026-03-03 05:19","pubTimestamp":1772486349,"startTime":"0","endTime":"0","summary":"Ecopetrol SA  expected to post earnings of34cents a share - Earnings Preview Ecopetrol SA EC.N, EC is expected to  show a fall in quarterly revenue when it reports  results on March 4 for the period e","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nL8N3ZQ2YY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4201","EC"],"gpt_icon":0},{"id":"2616737488","title":"Rhythm Pharmaceuticals Announces Additional Positive Data from Phase 3 TRANSCEND trial of Setmelanotide in Patients with Acquired Hypothalamic Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2616737488","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616737488?lang=en_us&edition=fundamental","pubTime":"2026-03-02 01:30","pubTimestamp":1772386200,"startTime":"0","endTime":"0","summary":"-- -18.8% placebo-adjusted difference in BMI reduction achieved in all patients (N=142) at 52 weeks, including 12 Japanese patients and 10 supplemental patients with acquired hypothalamic obesity --  ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/01/3246959/0/en/Rhythm-Pharmaceuticals-Announces-Additional-Positive-Data-from-Phase-3-TRANSCEND-trial-of-Setmelanotide-in-Patients-with-Acquired-Hypothalamic-Obesity.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4201","BK4215","BK4588","CHMP","MAA","VUS","EMA","BK4081","EC","BK4585","BK4087"],"gpt_icon":0},{"id":"2614858056","title":"X4 Pharmaceuticals Receives Positive Opinion from the EMA CHMP Recommending Approval of Mavorixafor in the EU for WHIM Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2614858056","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614858056?lang=en_us&edition=fundamental","pubTime":"2026-02-27 20:00","pubTimestamp":1772193600,"startTime":"0","endTime":"0","summary":"- Potential First and Only Therapy in the EU for Ultra-Rare Immune Disorder - BOSTON, Feb.  27, 2026  (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company focused on improving the lives of","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/27/3246423/0/en/X4-Pharmaceuticals-Receives-Positive-Opinion-from-the-EMA-CHMP-Recommending-Approval-of-Mavorixafor-in-the-EU-for-WHIM-Syndrome.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EMA","EC","LU2265009873.SGD","BK4198","BK4087","ALC","BK4156","BK4534","LU1804176565.USD","CHMP","BK4201","BK4081"],"gpt_icon":0},{"id":"2614071500","title":"Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2614071500","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614071500?lang=en_us&edition=fundamental","pubTime":"2026-02-27 05:05","pubTimestamp":1772139900,"startTime":"0","endTime":"0","summary":"PALSONIFY (Paltusotine) Net Product Revenue of $5.4 Million for Fourth-Quarter 2025, with >200 Enrollment Forms at the End of December Operationally Seamless Phase 2/3 Study of Atumelnant for the Trea","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/26/3246079/0/en/Crinetics-Pharmaceuticals-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4087","LU0211328371.USD","LU0211327993.USD","BK4585","LU1267930490.SGD","LU0310800965.SGD","LU0162691827.USD","CAH","LU1880398471.USD","LU0006061336.USD","LU1267930813.SGD","BK4588","CHMP","LU0889566641.SGD","LU0154236417.USD","EMA","LU0310799852.SGD","BK4201","BK4175","LU1880398554.USD","LU0792757196.USD","LU1267930227.SGD","LU0128525689.USD","LU1571399168.USD","SG9999001440.SGD","BK4081","LU0052756011.USD","LU0072461881.USD","EC"],"gpt_icon":0},{"id":"2614771736","title":"Global Masters Fund Updates Management Services Agreement With EC Pohl & Co","url":"https://stock-news.laohu8.com/highlight/detail?id=2614771736","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614771736?lang=en_us&edition=fundamental","pubTime":"2026-02-25 12:32","pubTimestamp":1771993965,"startTime":"0","endTime":"0","summary":"Global Masters Fund Limited ( ($AU:GFL) ) has shared an update. Global Masters Fund Limited has executed an amendment to its Management Services Ag...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/global-masters-fund-updates-management-services-agreement-with-ec-pohl-co?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/global-masters-fund-updates-management-services-agreement-with-ec-pohl-co?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4201","LU2236285917.USD","LU2211815571.USD","BK4120","GFL","EC","LU2463526074.USD"],"gpt_icon":0},{"id":"1184760177","title":"Earning Preview: Ecopetrol SA Q4 revenue is expected to decrease by 14.28%, and institutional views are cautious","url":"https://stock-news.laohu8.com/highlight/detail?id=1184760177","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184760177?lang=en_us&edition=fundamental","pubTime":"2026-02-25 10:42","pubTimestamp":1771987323,"startTime":"0","endTime":"0","summary":"AbstractEcopetrol SA will report its quarterly results on March 04, 2026 Post Market; investors will watch how revenue, margins, and EPS track against guidance amid a new Colombian tax assessment and...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Earning Preview: Ecopetrol SA Q4 revenue is expected to decrease by 14.28%, and institutional views are cautious","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EC"],"gpt_icon":0},{"id":"2613735122","title":"J&J reports EC approved extension of Rybrevant marketing authorization","url":"https://stock-news.laohu8.com/highlight/detail?id=2613735122","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613735122?lang=en_us&edition=fundamental","pubTime":"2026-02-24 00:25","pubTimestamp":1771863914,"startTime":"0","endTime":"0","summary":"Johnson & Johnson announced that the European Commission has approved an extension of the Rybrevant marketing authorization to include additional s...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jj-reports-ec-approved-extension-of-rybrevant-marketing-authorization-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jj-reports-ec-approved-extension-of-rybrevant-marketing-authorization-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1061106388.HKD","BK4504","JNJ","IE00BKVL7J92.USD","LU1032466523.USD","LU1244550577.SGD","LU0432979614.USD","LU1162221912.USD","LU2471134523.USD","IE00BLSP4239.USD","LU2430703178.SGD","IE00B19Z3B42.SGD","LU1267930813.SGD","SG9999001440.SGD","LU1674673691.USD","EC","LU0058720904.USD","IE00BBT3K403.USD","LU0683600562.USD","LU0787776722.HKD","LU0234570918.USD","LU1894683264.USD","LU2505996681.GBP","BK4559","LU0124676726.USD","LU1894683348.USD","LU1430594728.SGD","IE000M9KFDE8.USD","LU1674673428.USD","IE00BGHQF631.EUR","LU2089984988.USD","BK4581","LU2471134952.CNY","LU0795875086.SGD","IE00BFTCPJ56.SGD","BK4568","LU0289739699.SGD","LU1057294990.SGD","LU0689626769.HKD","IE00B4R5TH58.HKD","LU0122379950.USD","LU1496350502.SGD","LU1066053197.SGD","BK4532","LU0882574055.USD","IE00B3PB1722.GBP","BK4533","BK4585","LU2347655156.SGD","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2613105782","title":"Key Opinion Leader (KOL) Panel to Discuss Acrivon’s ACR-368 Endometrial Cancer (EC) Trial during the 2026 European Society of Gynecological Oncology (ESGO) Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2613105782","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613105782?lang=en_us&edition=fundamental","pubTime":"2026-02-23 21:00","pubTimestamp":1771851600,"startTime":"0","endTime":"0","summary":"Live webcast of event on February 27 at 8:00 a.m. ET will include participation of globally renowned gynecological oncology KOLs from the US and EU KOL panel to discuss maturing data from the ACR-368 ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/23/3242600/0/en/Key-Opinion-Leader-KOL-Panel-to-Discuss-Acrivon-s-ACR-368-Endometrial-Cancer-EC-Trial-during-the-2026-European-Society-of-Gynecological-Oncology-ESGO-Congress.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KOL","BK4201","ACR","EC","BK4110"],"gpt_icon":0},{"id":"2612585972","title":"Press Release: Ecopetrol S.A. Board of Directors Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=2612585972","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612585972?lang=en_us&edition=fundamental","pubTime":"2026-02-20 10:26","pubTimestamp":1771554360,"startTime":"0","endTime":"0","summary":"BOGOTA, Colombia, Feb. 19, 2026 /PRNewswire/ -- Ecopetrol S.A.   informs that the board of directors, in its session held on February 18 and 19, 2026, elected ngela María Robledo Gómez and Hildebrando Vélez Galeano as chairwoman and vice chairman of the board of directors, respectively.The board of directors also appointed members for its supporting committees as follows:. Additionally, Ecopetrol welcomes the new members of the board of directors, Dr. Carolina Arias Hurtado and Drs. Juan Gonzalo Castao Valderrama and Cesar Eduardo Loza Arenas. We extend our best wishes for a successful tenure on the board.Ecopetrol is the largest company in Colombia and one of the main integrated energy companies in the American continent, with more than 19,000 employees. In Colombia, it is responsible for more than 60% of the hydrocarbon production of most transportation, logistics, and hydrocarbon refining systems, and it holds leading positions in the petrochemicals and gas distribution segments. Wi","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EC","BK4201"],"gpt_icon":0},{"id":"2612465366","title":"MYQORZO: EC Approval, Differentiated Label, and Global HCM Expansion Support Buy on CYTK","url":"https://stock-news.laohu8.com/highlight/detail?id=2612465366","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612465366?lang=en_us&edition=fundamental","pubTime":"2026-02-17 23:25","pubTimestamp":1771341924,"startTime":"0","endTime":"0","summary":"Analyst Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Cytokinetics and keeping the price target at $136.00. Joseph Pantginis has...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/myqorzo-ec-approval-differentiated-label-and-global-hcm-expansion-support-buy-on-cytk-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/myqorzo-ec-approval-differentiated-label-and-global-hcm-expansion-support-buy-on-cytk-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4531","BK4139","BK4585","BK4588","EC","BK4505","CYTK","BK4201","HCM"],"gpt_icon":0},{"id":"2612645751","title":"Rhythm Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 26, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2612645751","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612645751?lang=en_us&edition=fundamental","pubTime":"2026-02-17 21:00","pubTimestamp":1771333200,"startTime":"0","endTime":"0","summary":"BOSTON, Feb.  17, 2026  (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with r","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/17/3239204/0/en/Rhythm-Pharmaceuticals-to-Report-Fourth-Quarter-and-Full-Year-2025-Financial-Results-on-Thursday-February-26-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EC","VUS","BK4201"],"gpt_icon":0},{"id":"2612452611","title":"Moderna receives EC marketing authorization for mNEXSPIKE","url":"https://stock-news.laohu8.com/highlight/detail?id=2612452611","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612452611?lang=en_us&edition=fundamental","pubTime":"2026-02-17 20:55","pubTimestamp":1771332943,"startTime":"0","endTime":"0","summary":"Moderna (MRNA) announced that the European Commission, EC, has granted marketing authorization for mNEXSPIKE, a new COVID vaccine, for active immun...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderna-receives-ec-marketing-authorization-for-mnexspike-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderna-receives-ec-marketing-authorization-for-mnexspike-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4201","EC","BK4532","BK4548","BK4534","BK4139","MRNA","BK4551","BK4501","BK4568","BK4588","BK4585","BK4533"],"gpt_icon":0},{"id":"2611815741","title":"Press Release: Equinor ASA: Buy-back of shares to share programmes for employees","url":"https://stock-news.laohu8.com/highlight/detail?id=2611815741","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611815741?lang=en_us&edition=fundamental","pubTime":"2026-02-13 21:26","pubTimestamp":1770989160,"startTime":"0","endTime":"0","summary":"Equinor ASA  has on 4 February 2026 engaged a third party to conduct repurchases of the company's shares to be used in the share-based incentive plans for employees and management for the period from 13 February 2026 until 15 January 2027.Shares acquired under the buy-back programme from 13 February 2026 to 12 May 2026 is based upon the authorization from the annual general meeting on 14 May 2025, registered in the Norwegian register for business enterprises. According to the authorization, the maximum number of shares to be purchased in the market is 14,400,000, the minimum price that can be paid per share is NOK 50, and the maximum price is NOK 1,000. Share buy-back after 12 May 2026 is subject to a new authorization from the annual general meeting in 2026.The buy-back programme is time-scheduled, and the share purchases shall take place on specific dates in the period from 13 February 2026 until 15 January 2027 with a determined purchase amount on each date, as set out in the buy-ba","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EQNR","BK4585","BK4588","EC","ASA","BK4201"],"gpt_icon":0},{"id":"2611132748","title":"Smaregi to Absorb EC Unit Netshop Supporters in Simplified Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=2611132748","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611132748?lang=en_us&edition=fundamental","pubTime":"2026-02-13 17:09","pubTimestamp":1770973784,"startTime":"0","endTime":"0","summary":"Smaregi  will merge its wholly owned subsidiary Netshop Supporters through a simplified absorption-type merger, effective May 1, according to a Friday filing on the Tokyo Stock Exchange.The merger follows Smaregi's acquisition of Netshop Supporters in December 2024 and aims to integrate management, development, and organizational structures to strengthen coordination between point-of-sale, payment, customer management, and e-commerce operations.Smaregi will be the surviving company, with no issuance of new shares or cash consideration.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EC","BK4201"],"gpt_icon":0},{"id":"1139404580","title":"Ecopetrol Shares Rise Amid Weak Pre-Holiday Freight Rate Drivers","url":"https://stock-news.laohu8.com/highlight/detail?id=1139404580","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139404580?lang=en_us&edition=fundamental","pubTime":"2026-02-13 10:21","pubTimestamp":1770949301,"startTime":"0","endTime":"0","summary":"Freight rate drivers are weak ahead of the holiday period. The EC2604 contract is expected to experience volatile movement in the near term, with attention focused on the implementation of shipping...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EC","BK4201"],"gpt_icon":0},{"id":"2609261308","title":"Rhythm Pharmaceuticals Announces Participation in Upcoming Guggenheim Biotech Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2609261308","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609261308?lang=en_us&edition=fundamental","pubTime":"2026-02-05 21:00","pubTimestamp":1770296400,"startTime":"0","endTime":"0","summary":"BOSTON, Feb.  05, 2026  (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with r","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/05/3232922/0/en/Rhythm-Pharmaceuticals-Announces-Participation-in-Upcoming-Guggenheim-Biotech-Summit.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VUS","BK4588","BK4201","SMMF","EC","BK4585","LABU","BK4211"],"gpt_icon":0},{"id":"2608395131","title":"Ecopetrol downgraded to Underperform from Outperform at Bradesco BBI","url":"https://stock-news.laohu8.com/highlight/detail?id=2608395131","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608395131?lang=en_us&edition=fundamental","pubTime":"2026-02-04 23:30","pubTimestamp":1770219028,"startTime":"0","endTime":"0","summary":"Bradesco BBI downgraded Ecopetrol (EC) to Underperform from Outperform with an unchanged price target of $12. Published first on TheFly – the ultim...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ecopetrol-downgraded-to-underperform-from-outperform-at-bradesco-bbi-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ecopetrol-downgraded-to-underperform-from-outperform-at-bradesco-bbi-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EC","BK4201"],"gpt_icon":0},{"id":"2607510060","title":"Is EC Healthcare (HKG:2138) Using Too Much Debt?","url":"https://stock-news.laohu8.com/highlight/detail?id=2607510060","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607510060?lang=en_us&edition=fundamental","pubTime":"2026-01-30 08:44","pubTimestamp":1769733860,"startTime":"0","endTime":"0","summary":"Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/3112800-choice2-main-header/1585186996564","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3112800-choice2-main-header/1585186996564"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/consumer-services/hkg-2138/ec-healthcare-shares/news/is-ec-healthcare-hkg2138-using-too-much-debt-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/consumer-services/hkg-2138/ec-healthcare-shares/news/is-ec-healthcare-hkg2138-using-too-much-debt-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4581","BK4585","EC","BK4588","BK1593","XBI","XLV","BK1511","LABU","02138","BK1215","EBIT","BK4201"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ecopetrol.com.co","stockEarnings":[{"period":"1week","weight":-0.0588},{"period":"1month","weight":-0.07},{"period":"3month","weight":0.154},{"period":"6month","weight":0.2931},{"period":"1year","weight":0.2344},{"period":"ytd","weight":0.1667}],"compareEarnings":[{"period":"1week","weight":-0.0102},{"period":"1month","weight":-0.0168},{"period":"3month","weight":-0.0052},{"period":"6month","weight":0.0481},{"period":"1year","weight":0.1654},{"period":"ytd","weight":-0.0023}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Ecopetrol S.A. operates as an integrated energy company. The company operates through four segments: Exploration and Production; Transport and Logistics; Refining, Petrochemical and Biofuels; and Electric Power Transmission and Toll Roads Concessions. It engages in the exploration and production of oil and gas; transportation of crude oil, motor fuels, fuel oil, and other refined products, including diesel, jet, and biofuels; processing and refining crude oil; distribution of natural gas and LPG; sale of refined and petrochemical products; supplying of electric power transmission services; design, development, construction, operation, and maintenance of road and energy infrastructure projects; and supplying of information technology and telecommunications services. As of December 31, 2022, the company had approximately 9,127 kilometers of crude oil and multi-purpose pipelines. It also produces and commercializes polypropylene resins and compounds, and masterbatches; and offers industrial service sales to customers and specialized management services. It has operations in Colombia, the United States, Asia, Central America and the Caribbean, Europe, and South America. The company was formerly known as Empresa Colombiana de Petróleos and changed its name to Ecopetrol S.A. in June 2003. Ecopetrol S.A. was incorporated in 1948 and is headquartered in Bogotá, Colombia.","yearOnYearQuotes":[{"month":1,"riseRate":0.611111,"avgChangeRate":0.047964},{"month":2,"riseRate":0.5,"avgChangeRate":0.012901},{"month":3,"riseRate":0.666667,"avgChangeRate":0.019697},{"month":4,"riseRate":0.470588,"avgChangeRate":-0.009586},{"month":5,"riseRate":0.352941,"avgChangeRate":-0.016936},{"month":6,"riseRate":0.470588,"avgChangeRate":0.005743},{"month":7,"riseRate":0.470588,"avgChangeRate":0.007592},{"month":8,"riseRate":0.470588,"avgChangeRate":0.000807},{"month":9,"riseRate":0.470588,"avgChangeRate":-0.011239},{"month":10,"riseRate":0.611111,"avgChangeRate":-0.007073},{"month":11,"riseRate":0.444444,"avgChangeRate":-0.030395},{"month":12,"riseRate":0.611111,"avgChangeRate":0.009975}],"exchange":"NYSE","name":"Ecopetrol SA","nameEN":"Ecopetrol SA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ecopetrol SA(EC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Ecopetrol SA(EC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Ecopetrol SA,EC,Ecopetrol SA股票,Ecopetrol SA股票老虎,Ecopetrol SA股票老虎国际,Ecopetrol SA行情,Ecopetrol SA股票行情,Ecopetrol SA股价,Ecopetrol SA股市,Ecopetrol SA股票价格,Ecopetrol SA股票交易,Ecopetrol SA股票购买,Ecopetrol SA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ecopetrol SA(EC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Ecopetrol SA(EC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}